Cardiology Stem Cells Market to Hit US$ 4.79 Billion by 2031, Says Growth Plus Reports

Newark, New Castle, USA, July 05, 2023 (GLOBE NEWSWIRE) — According to the latest analysis conducted by Growth Plus Reports, the global cardiology stem cells market was valued at approximately US$ 2.54 billion in 2022. It is anticipated to grow at a compound annual growth rate (CAGR) of 7.32% and reach a market value of approximately US$ 4.79 billion by 2031.

The global market for cardiology stem cells was analyzed and is expected to rise significantly during the forecast period. Undifferentiated stem cells can develop into multiple cell types, including heart cells. Stem cells are being researched in cardiology for their potential application in regenerative medicine, specifically for repairing damaged heart tissue.

Request a Free Sample Copy of the Research Report: https://www.growthplusreports.com/inquiry/request-sample/cardiology-stem-cells-market/8758

                                           Cardiology Stem Cells Market Scope

Key Takeaways:

• The rising prevalence of cardiovascular disorders and regenerative medicine is driving the market revenue share.
• The ability to improve cardiac performance and reduce heart damage in preclinical and clinical studies is driving the demand.
• Advancements in cardiology stem cell approaches are driving the market demand.
• Recent Development in the Global Cardiology Stem Cells Market:
• In December 2022, A phase I/II clinical trial of Bio Cardia Inc.’s Neurokinin-1 receptor positive (NK1R+) allogeneic human mesenchymal stem cell (MSC) therapy for the treatment of patients with ischemic heart failure has been approved by the FDA.

Competitive Landscape:

A list of the top market players operating in the global cardiology stem cells market includes:

• STEMCELL Technologies 
• BrainStorm Cell Therapeutics.
• Takara Bio Inc
• Astellas Pharma Inc.
• BioTimes Inc.

Market Drivers and Restraints:

The global cardiology stem cells market revenue is driven by increasing demand for regenerative medicine in cardiovascular diseases and advancements in cardiology stem cells. Furthermore, the effectiveness of cardiac stem cells is rising thanks to new stem cell delivery techniques that contribute to market revenue growth.

However, the high cost of stem cell therapy and regulatory guidelines are expected to restrain revenue growth of the global cardiology stem cells market.

Market Segmentation:

Segmentation By Type of Cells

Based on the type of cells, the global cardiology stem cells market is segmented into embryonic stem cells, cord blood stem cells and amniotic fluid stem cells, adult stem cells, and induced pluripotent stem cells. Due to the prevalence of cardiovascular diseases and the growing demand for an effective treatment option, the adult stem cells segment accounts for the largest market revenue share.

Segmentation By Source

Based on the sources, the global cardiology stem cells market is segmented into autologous and allogeneic stem cells. The autologous segment accounts for the largest revenue share due to the high matching rate with the patients, lesser risk of rejections, and safest to use, as these are derived from the patient’s body.

Segmentation By Application

Based on the application, the global cardiology stem cells market is segmented into heart failure, myocardial infarction, critical limb ischemia, and others. The heart failure segment accounts for the largest revenue share due to the rising prevalence of cardiac failure cases and the demand for stem cell therapies.

Segmentation By End-User

Based on the end-user, the global cardiology stem cells market is segmented into pharmaceutical & biotechnology companies, academic & research institutes, hospitals & cell banks. The hospitals & cell bank segment accounts for the largest revenue share due to the prevalence of cardiovascular diseases and the growing adoption of stem cell therapies.

Regional Growth Dynamics

Based on the region, the global cardiology stem cells market is segmented into North America, Asia Pacific, Latin America, Europe, and the Middle East & Africa. Due to the attributed North America’s developed healthcare system, high frequency of cardiovascular illnesses, and widespread use of stem cell therapies, North America accounts for the largest revenue share in the global market.

Request for Customization – https://www.growthplusreports.com/inquiry/customization/cardiology-stem-cells-market/8758

Report Coverage

Growth Plus Reports studied the global market for cardiology stem cells in-depth. Basic market features, important investment sectors, analyses of regional growth, revenue projections, rival market participants, and mergers and acquisitions were all examined.

Table of Content

1. INTRODUCTION
   1. Market Ecosystem
   2. Timeline Under Consideration
      1. Historical Years – 2021
      2. Base Year – 2022
      3. Forecast Years – 2023 to 2031
   3. Currency Used in the Report
2. RESEARCH METHODOLOGY 
   1. Research Approach
   2. Data Collection Methodology
   3. Data Sources
      1. Secondary Sources 
      2. Primary Sources 
   4. Market Estimation Approach
      1. Bottom Up
      2. Top Down 
   5. Market Forecasting Model
   6. Limitations and Assumptions
3. PREMIUM INSIGHTS
   1. Current Market Trends (COVID-19 Perspective)
   2. Key Players & Competitive Positioning (2022)
   3. Regulatory Landscape
4. MARKET DYNAMICS
   1. Drivers
   2. Restraints/Challenges
   3. Opportunities
5. GLOBAL CARDIOLOGY STEM CELLS MARKET – ANALYSIS & FORECAST, BY TYPES OF CELLS
   1. Embryonic Stem Cells
   2. Cord Blood Stem Cells and Amniotic Fluid Stem Cells
   3. Adult Stem Cells 
   4. Induced Pluripotent Stem Cells                                             
6. GLOBAL CARDIOLOGY STEM CELLS MARKET – ANALYSIS & FORECAST, BY SOURCE
   1. Autologous
   2. Allogenic
7. GLOBAL CARDIOLOGY STEM CELLS MARKET – ANALYSIS & FORECAST, BY APPLICATION
   1. Heart Failure
   2. Myocardial Infarction
   3. Critical Limb Ischemia
   4. Others
8. GLOBAL CARDIOLOGY STEM CELLS MARKET – ANALYSIS & FORECAST, BY END USER 
   1. Pharmaceutical & Biotechnology Companies
   2. Academic & Research Institutes
   3. Hospitals & Cell Banks

CARDIOLOGY STEM CELLS MARKET TOC

Buy this Premium Research Report: https://www.growthplusreports.com/checkout-8758

VALUE PROPOSITIONS RELATED TO THE REPORT:

• Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
• Comprehensive quantitative and qualitative insights at segment and sub-segment level
• Covid 19 impact trends and perspective
• Granular insights at global/regional/country level
• Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
• Blanket coverage on competitive landscape
• Winning imperatives
• Exhaustive coverage on ‘Strategic Developments’ registered by leading players of the market.

CUSTOMIZATION OPTIONS:

• Distributor Landscape Assessment
• Pricing Intelligence
• Customer Base Assessment
• Investment & Initiatives Analysis
• ‘Business Profile’ of Key Players

Schedule a call with our analyst: https://appoint.ly/s/salesZ3Jvd3RocGx1c3JlcG9ydHMuY29t/introduction

Visit our report store at – https://www.growthplusreports.com/report-store

Browse more latest healthcare reports:

Subcutaneous Immunoglobulin (SCIg) Therapy Market by Indication (Primary Immunodeficiency Disease, Chronic Inflammatory Demyelinating Polyneuropathy), Distribution Channel (Hospital Pharmacies, Online Pharmacies) – Global Outlook & Forecast 2023-2031

Acute Flaccid Myelitis Market by Treatment Type (Pharmacological Treatment, Physical & Occupational Therapy, Plasmapheresis, and Others) – Global Outlook & Forecast 2023-2031

Cell & Gene Therapy Clinical Trials Market by Phase (Phase I, Phase II), Indication (Oncology, Cardiology) – Global Outlook & Forecast 2023-2031

Cementless Total Knee Arthroplasty Market by Product Type (Fixed Bearing, Mobile Bearing), By End User (Hospitals, Specialty Surgical Centers) – Global Outlook and Forecast 2023-2031

Dermatology Endoscopy Devices Market by Product (Non-Polarized, Polarized), Type (Digital Dermato-scopes, Traditional/Analogue Dermato-scopes), Modality (Trolley-mounted, Handheld), Application (Scabies, Skin Cancer) – Global Outlook & Forecast 2023-2031

Unleashing the Power of Innovation in Med Tech:  https://growthplusmedtechroundup.com

About Us:

Growth Plus Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).

Growth Plus portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.

We were awarded by the prestigious CEO Magazine as “Most Innovative Healthcare Market Research Company in 2020”.